Pluslife Near-POC TB Diagnostic Solution Gains Recognition in Global TB Implementation Discussion

Pluslife's near-point-of-care (near-POC) TB diagnostic solution has been referenced in two recent international webinars focused on the introduction and scale of emerging TB diagnostics.
In PATH's webinar on sustainable introduction and scale of emerging TB solutions, Pluslife was highlighted as part of the near-POC TB diagnostic landscape, within a broader discussion on making TB testing more accessible and implementable. The platform's compact molecular testing design and support for decentralized placement were noted as relevant features for TB programs working closer to communities.
In a separate GC8 Community of Practice webinar on the roll-out of new TB diagnostics, the Pluslife MiniDock MTB platform was discussed more specifically, covering its near-POC testing capabilities, support for both sputum and tongue swab sample types, availability through the GDF catalogue, and implementation experience from Cameroon.
Across both discussions, Pluslife MiniDock MTB was recognized for its potential to support decentralized TB diagnosis and bring molecular testing closer to patients, particularly in peripheral facilities and settings with limited access to on-site testing infrastructure.